Literature DB >> 3742952

Aminoglycoside volume of distribution in hematology-oncology patients.

R P Manny, P R Hutson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3742952

Source DB:  PubMed          Journal:  Clin Pharm        ISSN: 0278-2677


× No keyword cloud information.
  9 in total

1.  Population pharmacokinetic study of amikacin administered once or twice daily to febrile, severely neutropenic adults.

Authors:  M Tod; O Lortholary; D Seytre; R Semaoun; B Uzzan; L Guillevin; P Casassus; O Petitjean
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

2.  Netilmicin pharmacokinetics in Hong Kong Chinese cancer patients.

Authors:  S Chang; R C Li; L S Chan; S Y Wong; M Zhu; A T Chan; K Raymond
Journal:  Br J Clin Pharmacol       Date:  1999-07       Impact factor: 4.335

3.  Gentamicin pharmacokinetics, nephrotoxicity, and prediction of mortality in febrile neutropenic patients.

Authors:  T M Bianco; P N Dwyer; J S Bertino
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

4.  Pharmacokinetics of amikacin in hematologic malignancies.

Authors:  S Kaojarern; S Maoleekoonpairoj; V Atichartakarn
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

5.  Gentamicin pharmacokinetics in patients with malignancies.

Authors:  J S Bertino; L A Booker; P Franck; B Rybicki
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

6.  Relative pharmacokinetics of three amikacin brands in onco-hemotologic pediatric patients experiencing febrile neutropeina.

Authors:  Muhammad Jamshaid; Samia Yousuf; Nadeem Irfan Bukhari; Amir Ali Rizvi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2003 Jan-Mar       Impact factor: 2.441

7.  Amikacin pharmacokinetics in patients receiving high-dose cancer chemotherapy.

Authors:  R L Davis; D Lehmann; C A Stidley; J Neidhart
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

8.  Aminoglycoside forecasting in neutropenic patients with cancer.

Authors:  J L Kosirog; R M Rospond; C Destache; P Hall
Journal:  Clin Pharmacokinet       Date:  1993-01       Impact factor: 6.447

9.  Population pharmacokinetics of gentamicin in patients with cancer.

Authors:  M C Rosario; A H Thomson; D I Jodrell; C A Sharp; H L Elliott
Journal:  Br J Clin Pharmacol       Date:  1998-09       Impact factor: 4.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.